Clinical Trials Browser

Unknown × Has results × Hodgkin Disease × Clear all

NCT03077828 2023-06-02

Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase 2 Unknown

43 enrolled 9 charts

Hodgkin Disease